Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement

Recruiting Observational Study
Diabetes
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
30 (estimated)
Sponsor
Centre Hospitalier Sud Francilien · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Older than 18 years patient with type 1 or 2 diabetes * Treated with multiple insulin injections * Equipped with a continuous glucose measurement system and smart connected insulin pens at least one month before * Dependent on a health professional for treatment management. * …
Contacts

Marie BOULY, APN

01 61 69 35 93

marie.bouly@chsf.fr

CONTACT

Caroline TOURTE

01 61 69 31 50

caroline.tourte@chsf.fr

CONTACT